1985至2021年丹麦重症肌无力发病率变化:一项全国性人群研究
该研究基于丹麦全国患者登记库,纳入1985至2021年18岁及以上新发重症肌无力(MG)患者,计算并分性别、年龄段比较发病率。共识别2110例患者,总发病率为1.4/10万人年(95%CI 1.3-1.4),早发型保持稳定,晚发型和极晚发型发病率随时间上升,发病率比分别为1.9(95%CI 1.3-2.6)和2.2(95%CI 1.7-2.9)。
要点
- 总MG发病率为1.4/10万人年(95%CI 1.3-1.4),男女间无显著差异。
- 早发型(≤50岁)发病率0.7(95%CI 0.6-0.7),研究期间保持稳定。
- 晚发型和极晚发型发病率上升,发病率比分别为1.9和2.2。
核心结论
- MG总体发病率从1985至2021年上升,与邻国近期报告一致;增长仅见于晚发型和极晚发型年龄组。
研究设计与样本
- 全国性人群研究,基于丹麦国家患者登记库1985至2021年数据,纳入18岁及以上新发MG诊断患者,共2110例(女性1060例),按发病年龄分为早发型(≤50岁)、晚发型(>50且≤65岁)和极晚发型(>65岁)。
- 敏感性分析从1995年至2021年,增加≥2次吡啶斯的明处方和/或乙酰胆碱受体血清阳性条件。
主要发现
- 女性中位年龄57.1岁(IQR 40.2-74.0),男性63.6岁(IQR 56.4-74.3)。
- 研究期间总体MG发病率为1.4(95%CI 1.3-1.4)/10万人年,敏感性分析结果持续,男女间无显著差异。
- 579例(27.4%)为早发型,490例(23.2%)为晚发型,1040例(49.3%)为极晚发型。
- 早发型MG发病率0.7(95%CI 0.6-0.7),研究期间保持稳定。
- 晚发型和极晚发型发病率随时间上升,从1985至1990年最初5年至2015至2021年最后6年,发病率比分别为1.9(95%CI 1.3-2.6)和2.2(95%CI 1.7-2.9)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Previous studies on incident myasthenia gravis (MG) have shown inconsistent results. In this study, we determined the MG incidence rates (IRs) over a 36-year period to detect potential trends in MG incidence over time and for different age groups. METHODS: In this nationwide population-based study from 1985 to 2021, we identified patients aged 18 and older with a primary MG diagnosis in the Danish National Patient Registry. The patients were categorized into 3 distinct groups defined by age at onset: early-onset (≤50 years of age), late-onset (>50 and ≤65 years of age), and very late-onset (>65 years of age). MG IRs were calculated and stratified by sex and time periods in the specified age groups. To increase the validity of the MG IRs, we performed sensitivity analyses from 1995 until 2021, adding ≥2 prescriptions of pyridostigmine and/or acetylcholine receptor seropositivity. RESULTS: We identified 2,110 patients with MG (1,060 women), with a median age of 57.1 (interquartile range [IQR] 40.2-74.0) years for women and 63.6 (IQR 56.4-74.3) years for men. In the study period, the MG IR was 1.4 (95% CI 1.3-1.4) per 100,000 person-years, which persisted in our sensitivity analyses, with no significant differences between the sexes. Overall, 579 patients (27.4%) were classified as early-onset, 490 (23.2%) as late-onset, and 1,040 (49.3%) as very late-onset. For early-onset MG, the IR was 0.7 (95% CI 0.6-0.7) and remained stable throughout the study period. Inversely, the IRs for late-onset and very late-onset MG increased over time, with corresponding incidence rate ratios (IRRs) of 1.9 (95% CI 1.3-2.6) and 2.2 (95% CI 1.7-2.9), from the first 5 years from 1985 to 1990 until the last 6 years of the study period from 2015 to 2021. DISCUSSION: The overall IR of MG increased from 1985 to 2021, aligning with recent reports from neighboring European countries. The most significant rise occurred during the last 6 years of the study period compared with the first 5 years, with an IRR reaching 1.9 (95% CI 1.6-2.3). This increase in IRs was observed only in the late-onset and very late-onset age groups.
引用
- Jul Jarbæk Nielsen J, Levison L, Andersen H, et al. Changes in Myasthenia Gravis Incidence in Denmark From 1985 to 2021: A Nationwide Population-Based Study. Neurology. 2024. PMID: 39666916. doi:10.1212/WNL.0000000000210139
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。